Literature DB >> 28751466

Treatment-Refractory Sternocostoclavicular Hyperostosis.

Ralph Yachoui1, Mazen Kreidy2, Brian J Parker3.   

Abstract

Sternocostoclavicular hyperostosis (SCCH) is an infrequent chronic inflammatory disorder of the axial skeleton of unknown origin. SCCH goes often unrecognized due to a low level of awareness for the disorder. It typically presents with relapsing and remitting pain in the shoulder, neck, and anterior chest wall area with occasional swelling and tenderness of the sternoclavicular area. The diagnosis is confirmed radiologically by sclerosis and hyperostosis of the sternoclavicular joints. There have been several reports in which intravenous bisphosphonates and tumor necrosis factor-inhibitors have shown reasonable efficacy in the treatment of this disorder. We report a patient with a long history of SCCH in whom pamidronate 60 mg intravenously every 3 months for 3 years failed to reduce symptom severity and improve radiologic findings.
© 2017 Marshfield Clinic.

Entities:  

Keywords:  Bisphosphonates; Pamidronate; Sternocostoclavicular hyperostosis; Tumor necrosis factor-inhibitors

Mesh:

Substances:

Year:  2017        PMID: 28751466      PMCID: PMC5573521          DOI: 10.3121/cmr.2017.1352

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


  12 in total

1.  Pamidronate: a novel treatment for the SAPHO syndrome?

Authors:  H Marshall; J Bromilow; A L Thomas; N K Arden
Journal:  Rheumatology (Oxford)       Date:  2002-02       Impact factor: 7.580

2.  Successful treatment of SAPHO syndrome with zoledronic acid.

Authors:  Petros Kopterides; Dimitrios Pikazis; Christos Koufos
Journal:  Arthritis Rheum       Date:  2004-09

3.  [Sterno-costo-clavicular hyperostosis: a hitherto undescribed entity (author's transl)].

Authors:  H Köhler; E Uehlinger; J Kutzner; T R Weihrauch; L Wilbert; R Schuster
Journal:  Dtsch Med Wochenschr       Date:  1975-07-18       Impact factor: 0.628

4.  Rapid pain relief and remission of sternocostoclavicular hyperostosis after intravenous ibandronate therapy.

Authors:  Johann D Ringe; Herbert Faber; Parvis Farahmand
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

5.  Sternocostoclavicular hyperostosis: painful swelling of the sternum, clavicles, and upper ribs. Report of two new cases.

Authors:  H Köhler; E Uehlinger; J Kutzner; T B West
Journal:  Ann Intern Med       Date:  1977-08       Impact factor: 25.391

Review 6.  The sternoclavicular syndrome: experience from a district general hospital and results of a national postal survey.

Authors:  S Kalke; S D Perera; N D Patel; T E Gordon; B Dasgupta
Journal:  Rheumatology (Oxford)       Date:  2001-02       Impact factor: 7.580

7.  Sternocostoclavicular hyperostosis: a review.

Authors:  Matthew B Carroll
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-04       Impact factor: 5.346

8.  Diagnostic delay in sternocostoclavicular hyperostosis: impact on various aspects of quality of life.

Authors:  Willem A van der Kloot; Sadhna A Chotkan; Ad A Kaptein; Neveen A T Hamdy
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-02       Impact factor: 4.794

Review 9.  Sustained remission of SAPHO syndrome with pamidronate: a follow-up of fourteen cases and a review of the literature.

Authors:  M Colina; R La Corte; F Trotta
Journal:  Clin Exp Rheumatol       Date:  2009 Jan-Feb       Impact factor: 4.473

10.  Sternocostoclavicular Hyperostosis: An Ill-Recognized Disease.

Authors:  Bolette Roed; Tatiana Kristensen; Søren Thorsen; Klaus Poulsen Bloch; Pia Afzelius
Journal:  Diagnostics (Basel)       Date:  2016-08-05
View more
  1 in total

1.  Sternocostoclavicular Hyperostosis: Positive Clinical and Radiological Response on Pamidronate.

Authors:  Anne T Leerling; Ana Navas Cañete; Ashna I E Ramautar; Natasha M Appelman-Dijkstra; Elizabeth M Winter
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-18       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.